-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $107

Benzinga·06/29/2026 14:05:36
Listen to the news
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $60 to $107.